Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Horton

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Journal of Parasitology Research|August 6, 2024
In Silico Analysis of the ROP29 Protein as a Vaccine Candidate Against <i>Toxoplasma gondii</i>Amir Karimipour-Saryazdi, Fatemeh Ghaffarifar, Abdolhossein Dalimi, et al.
The Biochemical Journal|May 10, 2021
Histone H3 N-terminal mimicry drives a novel network of methyl-effector interactionsJianji Chen, John Horton, Cari Sagum, et al.
Iscience|November 15, 2018
DNA Sequence Context Controls the Binding and Processivity of the T7 DNA PrimaseAriel Afek, Stefan Ilic, John Horton, et al.
American Heart Journal|July 12, 2011
Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin useDeepak Voora, John Horton, Svati H Shah, et al.
Physics in Medicine and Biology|August 4, 2006
Comparison of dose distributions around the pulsed-dose-rate Fletcher-Williamson and the low-dose-rate Fletcher-Suit-Delclos ovoids: a Monte Carlo studyMichael J Price, Kent A Gifford, John Horton, et al.
British Journal of Clinical Pharmacology|November 18, 2009
Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazoleAhmed M Abdel-tawab, Mark Bradley, Essam A Ghazaly, et al.
Respiratory Care|February 22, 2011
High-grade primary pulmonary B cell lymphoma presenting as a necrotic massShaun Brown, John Horton, Domingo Rosario, et al.
Expert Review of Anti-Infective Therapy|December 4, 2018
Oxfendazole: a promising agent for the treatment and control of helminth infections in humansArmando E Gonzalez, Ellen E Codd, John Horton, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2021
Population Pharmacokinetic-Pharmacodynamic Model of Oxfendazole in Healthy Adults in a Multiple Ascending Dose and Food Effect Study and Target Attainment AnalysisThanh Bach, Gregory A Deye, Ellen E Codd, et al.
Plos Neglected Tropical Diseases|June 23, 2011
Potential drug development candidates for human soil-transmitted helminthiasesPiero Olliaro, Jürg Seiler, Annette Kuesel, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Journal of Parasitology Research|August 6, 2024
In Silico Analysis of the ROP29 Protein as a Vaccine Candidate Against <i>Toxoplasma gondii</i>Amir Karimipour-Saryazdi, Fatemeh Ghaffarifar, Abdolhossein Dalimi, et al.
The Biochemical Journal|May 10, 2021
Histone H3 N-terminal mimicry drives a novel network of methyl-effector interactionsJianji Chen, John Horton, Cari Sagum, et al.
Iscience|November 15, 2018
DNA Sequence Context Controls the Binding and Processivity of the T7 DNA PrimaseAriel Afek, Stefan Ilic, John Horton, et al.
American Heart Journal|July 12, 2011
Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin useDeepak Voora, John Horton, Svati H Shah, et al.
Physics in Medicine and Biology|August 4, 2006
Comparison of dose distributions around the pulsed-dose-rate Fletcher-Williamson and the low-dose-rate Fletcher-Suit-Delclos ovoids: a Monte Carlo studyMichael J Price, Kent A Gifford, John Horton, et al.
British Journal of Clinical Pharmacology|November 18, 2009
Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazoleAhmed M Abdel-tawab, Mark Bradley, Essam A Ghazaly, et al.
Respiratory Care|February 22, 2011
High-grade primary pulmonary B cell lymphoma presenting as a necrotic massShaun Brown, John Horton, Domingo Rosario, et al.
Expert Review of Anti-Infective Therapy|December 4, 2018
Oxfendazole: a promising agent for the treatment and control of helminth infections in humansArmando E Gonzalez, Ellen E Codd, John Horton, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2021
Population Pharmacokinetic-Pharmacodynamic Model of Oxfendazole in Healthy Adults in a Multiple Ascending Dose and Food Effect Study and Target Attainment AnalysisThanh Bach, Gregory A Deye, Ellen E Codd, et al.
Plos Neglected Tropical Diseases|June 23, 2011
Potential drug development candidates for human soil-transmitted helminthiasesPiero Olliaro, Jürg Seiler, Annette Kuesel, et al.
Pageof 12